Decentralized high-dose chemotherapy with autologous stem cell support;Regionalisert hoydose cellegiftbehandling med autolog stamcellestotte

Tidsskrift for den Norske Laegeforening

Volumn 118, Issue 18, 1998, Pages 2777-2780

  Husebekk, Anne ^a   Kolstad, Arne ^b   Dahl, Inger Marie S ^c   Skogen, Bjøŕn ^a  

^a Avdeling for Immunologi og Transfusjonsmedisin   (Norway)

^b Kreftavdelingen   (Norway)

^c Medisinsk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CD34 ANTIGEN; CISPLATIN; EPIRUBICIN; ERYTHROPOIETIN; ETOPOSIDE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; METHOTREXATE; MITOGUAZONE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; HODGKIN DISEASE; HUMAN; MULTIPLE MYELOMA; NEUTROPHIL; NONHODGKIN LYMPHOMA; STEM CELL TRANSPLANTATION; TESTIS CANCER; THROMBOCYTE; AUTOTRANSPLANTATION; BREAST TUMOR; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL MANAGEMENT; MALE; MULTIMODALITY CANCER THERAPY; NORWAY; TESTIS TUMOR;

ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CENTRALIZED HOSPITAL SERVICES; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MULTIPLE MYELOMA; NORWAY; TESTICULAR NEOPLASMS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0032504649     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Høydosebehandling med perifer stamcellestøtte ved maligne lidelser. Helsedirektoratets utredningsserie I-95. Oslo: Statens helsetilsyn, 1995.
2. Holte H, Kvaløy SO, Engan T, Evensen SA, Mella O, Tangen JM et al. Hoydosebehandling med perifer stamcellestøtte ved maligne lidelser. Tidsskr Nor Lægeforen 1996; 116: 2577-81.
3. Bezwoda WR, Seymour L, Dansey RD. High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. J Clin Oncol 1995; 10: 2483-9.
4. Attal M, Harousseau JL. Standard therapy versus autologous transplantation in multiple myeloma. Hematol Oncol Clin North Am 1997; 11: 133-6.
5. Armitage S, Hargreaves R, Samson D, Brennan M, Kanfer E, Navarrete C. CD34 counts to predict the adequate collection of peripheral blood progentitor cells. Bone Marrow Transplant 1997; 2: 587-91.
6. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo DS et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 1991; 28: 1525-33.
7. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J, Andersen FW et al. Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 1993; 341: 85-6.
8. Kvalheim G, Pharo A, Holte H, Jacobsen E, Erikstein B, Kvaloy S et al. Hoydosebehandling av kreft ved bruk av CD34-positive celler som stamcellestotte. Tidsskr Nor Leegeforen 1996; 116: 2542-6.
9. Takaue Y, Okamoto Y, Kawano Y, Suzue T, Abe T, Saito SI et al. Regeneration of immunity and varicella-zoster virus infection after high-dose chemotherapy and peripheral blood stem cell autografts in children. Bone Marrow Transplant 1994; 2: 219-23.
10. Oliveieri A, Offidani M, Cantori I, Ciniero L, Ombrosi L, Masia MC et al. Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization. Bone Marrow Transplant 1995; 16: 765-70.
11. Johnsen HE. Report from a Nordic workshop on CD34+ cell analysis: technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. Nordic Myeloma Study Group Laboratories. J Hematother 1995; 1: 21-8.
12. Johnsen HE, Knudsen LM. Nordic flow cytometry standards for CD34+ cell enumeration in blood and leukapheresis products: report from the second Nordic Workshop. Nordic Stem Cell Laboratory Group (NSCL-G). J Hematother 1996; 3: 237-45
13. Comenzo RL, Michelle D, LeBlanc M, Wally J, Zhang Y, Kica G et al. Mobilized CD34+ cells selected as autografts in patients with primary light-chain amyloidosis: rationale and application. Transfusion 1998; 38: 60-9.